STAT

The White House punted to Congress on opioids funding. Congress doesn’t have a plan

With fewer than two dozen days left on the 2017 legislative calendar, Congress is unlikely to create a major new stream of funding before the new year.

WASHINGTON — The Trump administration declared the opioid crisis a public health emergency two weeks ago. Six days later, a White House-appointed panel proposed a national drug court system, a dramatic increase in addiction treatment beds, and what President Trump called “really tough, really big, really great advertising” to warn of the perils of drug use.

Neither the White House nor Congress has suggested how to pay for those measures.

With fewer than two dozen days left on the 2017 legislative calendar, a contentious tax cut pending, and the specter of a government shutdown looming in December, Congress is unlikely to create a major new stream of funding before the new year. Key

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT1 min read
STAT+: Nuclear Regulatory Commission Advisers Beset By Conflicts Of Interest, Report Finds
Advisers to the Nuclear Regulatory Commission, a U.S. government agency tasked with ensuring the safe use of radioactive materials, were beset by conflicts of interest, report finds

Related